Boston Scientific sees profits triple

Boston Scientific said second-quarter profit almost tripled following the first full quarter of sales from its Taxus drug-coated device in the US.

Net income climbed to €258 million ($313m) from €94m ($114m) a year earlier, the company said in a statement.

Revenue surged 71% to €1.2bn ($1.46bn).